179 related articles for article (PubMed ID: 12900406)
1. Structural and functional uncoupling of the enzymatic and angiogenic inhibitory activities of tissue inhibitor of metalloproteinase-2 (TIMP-2): loop 6 is a novel angiogenesis inhibitor.
Fernández CA; Butterfield C; Jackson G; Moses MA
J Biol Chem; 2003 Oct; 278(42):40989-95. PubMed ID: 12900406
[TBL] [Abstract][Full Text] [Related]
2. An integrin-binding N-terminal peptide region of TIMP-2 retains potent angio-inhibitory and anti-tumorigenic activity in vivo.
Seo DW; Saxinger WC; Guedez L; Cantelmo AR; Albini A; Stetler-Stevenson WG
Peptides; 2011 Sep; 32(9):1840-8. PubMed ID: 21871510
[TBL] [Abstract][Full Text] [Related]
3. Tissue inhibitor of metalloproteinases-3 peptides inhibit angiogenesis and choroidal neovascularization in mice.
Qi JH; Ebrahem Q; Ali M; Cutler A; Bell B; Prayson N; Sears J; Knauper V; Murphy G; Anand-Apte B
PLoS One; 2013; 8(3):e55667. PubMed ID: 23469166
[TBL] [Abstract][Full Text] [Related]
4. Utilization of a novel recombinant myoglobin fusion protein expression system to characterize the tissue inhibitor of metalloproteinase (TIMP)-4 and TIMP-2 C-terminal domain and tails by mutagenesis. The importance of acidic residues in binding the MMP-2 hemopexin C-domain.
Kai HS; Butler GS; Morrison CJ; King AE; Pelman GR; Overall CM
J Biol Chem; 2002 Dec; 277(50):48696-707. PubMed ID: 12374789
[TBL] [Abstract][Full Text] [Related]
5. Davallia bilabiata exhibits anti-angiogenic effect with modified MMP-2/TIMP-2 secretion and inhibited VEGF ligand/receptors expression in vascular endothelial cells.
Liu CT; Bi KW; Huang CC; Wu HT; Ho HY; S Pang JH; Huang ST
J Ethnopharmacol; 2017 Jan; 196():213-224. PubMed ID: 27993633
[TBL] [Abstract][Full Text] [Related]
6. TIMP-2 mediated inhibition of angiogenesis: an MMP-independent mechanism.
Seo DW; Li H; Guedez L; Wingfield PT; Diaz T; Salloum R; Wei BY; Stetler-Stevenson WG
Cell; 2003 Jul; 114(2):171-80. PubMed ID: 12887919
[TBL] [Abstract][Full Text] [Related]
7. Cellular activation of MMP-2 (gelatinase A) by MT2-MMP occurs via a TIMP-2-independent pathway.
Morrison CJ; Butler GS; Bigg HF; Roberts CR; Soloway PD; Overall CM
J Biol Chem; 2001 Dec; 276(50):47402-10. PubMed ID: 11584019
[TBL] [Abstract][Full Text] [Related]
8. Sequence motifs of tissue inhibitor of metalloproteinases 2 (TIMP-2) determining progelatinase A (proMMP-2) binding and activation by membrane-type metalloproteinase 1 (MT1-MMP).
Worley JR; Thompkins PB; Lee MH; Hutton M; Soloway P; Edwards DR; Murphy G; Knäuper V
Biochem J; 2003 Jun; 372(Pt 3):799-809. PubMed ID: 12630911
[TBL] [Abstract][Full Text] [Related]
9. Coregulation of vascular tube stabilization by endothelial cell TIMP-2 and pericyte TIMP-3.
Saunders WB; Bohnsack BL; Faske JB; Anthis NJ; Bayless KJ; Hirschi KK; Davis GE
J Cell Biol; 2006 Oct; 175(1):179-91. PubMed ID: 17030988
[TBL] [Abstract][Full Text] [Related]
10. Delineating the molecular basis of the inactivity of tissue inhibitor of metalloproteinase-2 against tumor necrosis factor-alpha-converting enzyme.
Lee MH; Rapti M; Murphy G
J Biol Chem; 2004 Oct; 279(43):45121-9. PubMed ID: 15308656
[TBL] [Abstract][Full Text] [Related]
11. TIMP-2 mutant decreases MMP-2 activity and augments pressure overload induced LV dysfunction and heart failure.
Givvimani S; Kundu S; Narayanan N; Armaghan F; Qipshidze N; Pushpakumar S; Vacek TP; Tyagi SC
Arch Physiol Biochem; 2013 May; 119(2):65-74. PubMed ID: 23398532
[TBL] [Abstract][Full Text] [Related]
12. Tissue inhibitor of metalloproteinases-4 inhibits but does not support the activation of gelatinase A via efficient inhibition of membrane type 1-matrix metalloproteinase.
Bigg HF; Morrison CJ; Butler GS; Bogoyevitch MA; Wang Z; Soloway PD; Overall CM
Cancer Res; 2001 May; 61(9):3610-8. PubMed ID: 11325829
[TBL] [Abstract][Full Text] [Related]
13. Biophysical and functional characterization of full-length, recombinant human tissue inhibitor of metalloproteinases-2 (TIMP-2) produced in Escherichia coli. Comparison of wild type and amino-terminal alanine appended variant with implications for the mechanism of TIMP functions.
Wingfield PT; Sax JK; Stahl SJ; Kaufman J; Palmer I; Chung V; Corcoran ML; Kleiner DE; Stetler-Stevenson WG
J Biol Chem; 1999 Jul; 274(30):21362-8. PubMed ID: 10409697
[TBL] [Abstract][Full Text] [Related]
14. MMP-2/TIMP-2/TIMP-4 versus MMP-9/TIMP-3 in transition from compensatory hypertrophy and angiogenesis to decompensatory heart failure.
Givvimani S; Tyagi N; Sen U; Mishra PK; Qipshidze N; Munjal C; Vacek JC; Abe OA; Tyagi SC
Arch Physiol Biochem; 2010 May; 116(2):63-72. PubMed ID: 20230216
[TBL] [Abstract][Full Text] [Related]
15. Anti-angiogenic effect of Tanshinone IIA involves inhibition of matrix invasion and modification of MMP-2/TIMP-2 secretion in vascular endothelial cells.
Tsai MY; Yang RC; Wu HT; Pang JH; Huang ST
Cancer Lett; 2011 Nov; 310(2):198-206. PubMed ID: 21788102
[TBL] [Abstract][Full Text] [Related]
16. Characterization of the AB loop region of TIMP-2. Involvement in pro-MMP-2 activation.
Rapti M; Knaüper V; Murphy G; Williamson RA
J Biol Chem; 2006 Aug; 281(33):23386-94. PubMed ID: 16777853
[TBL] [Abstract][Full Text] [Related]
17. Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.
Gomez DE; Alonso DF; Yoshiji H; Thorgeirsson UP
Eur J Cell Biol; 1997 Oct; 74(2):111-22. PubMed ID: 9352216
[TBL] [Abstract][Full Text] [Related]
18. Tissue inhibitor of metalloproteinase-2 (TIMP-2) binds to the catalytic domain of the cell surface receptor, membrane type 1-matrix metalloproteinase 1 (MT1-MMP).
Zucker S; Drews M; Conner C; Foda HD; DeClerck YA; Langley KE; Bahou WF; Docherty AJ; Cao J
J Biol Chem; 1998 Jan; 273(2):1216-22. PubMed ID: 9422789
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase-10/TIMP-2 structure and analyses define conserved core interactions and diverse exosite interactions in MMP/TIMP complexes.
Batra J; Soares AS; Mehner C; Radisky ES
PLoS One; 2013; 8(9):e75836. PubMed ID: 24073280
[TBL] [Abstract][Full Text] [Related]
20. Matrix metalloproteinases cleave connective tissue growth factor and reactivate angiogenic activity of vascular endothelial growth factor 165.
Hashimoto G; Inoki I; Fujii Y; Aoki T; Ikeda E; Okada Y
J Biol Chem; 2002 Sep; 277(39):36288-95. PubMed ID: 12114504
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
